Eosera appoints Shilpi Jain as senior director of innovation
Jain brings a proven track record of innovation that will help propel eosera into its next chapter of growth.
Jain brings a proven track record of innovation that will help propel eosera into its next chapter of growth.
Director Monarez, the first Senate-confirmed director of the CDC, brings decades of frontline experience in disaster preparedness, biosecurity, and health innovation.
Jejurikar will replace Joe Moeller who will lead the board of directors and provide advice and counsel to the CEO on company matters.
Seasoned industry leader tapped to help pharma reimagine their go-to-market strategies and direct-to-patient models.
A recognized leader in retail media, Monahan brings extensive experience at dentsu, Pinterest and Walmart.com.
Vincent will replace Christine Wheatley who announced plans to retire on September 1.
“These leadership appointments reflect NACDS’ unwavering focus on member-driven progress and the advancement of chain pharmacy.”
Her appointment reflects the company’s commitment to evolving its consumer-centric approach and strengthening marketing as a commercial growth engine.
The leadership change comes amid strategic uncertainty for Kenvue.
He will succeed retiring CEO Michele Buck.
Ratner will lead AAM’s government relations team across federal and state relations, advocacy, and alliances.
In her new role at Nature's Path, she will lead the company's customer strategy across all U.S. channels, with a focus on expanding household penetration, retail partnerships, and accelerating Nature's Path's overall U.S. expansion.
“I’m thrilled to be joining such a dynamic and innovative brand,” said Haynes.
Agarwal also serves as corporate vice president, Packaging, Henkel Adhesive Technologies.
The appointment comes as PillSafe readies its product for commercial launch in early 2026.
“We are thrilled to welcome her to HDA,” said HDA’s Chief Policy Officer, Dr. Nicolette Louissaint.